z-logo
Premium
Structure–Activity Relationship Studies on ( R )‐PFI‐2 Analogues as Inhibitors of Histone Lysine Methyltransferase SETD7
Author(s) -
Lenstra Danny C.,
Damen Eddy,
Leenders Ruben G. G.,
Blaauw Richard H.,
Rutjes Floris P. J. T.,
Wegert Anita,
Mecinović Jasmin
Publication year - 2018
Publication title -
chemmedchem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201800242
Subject(s) - lysine , methyltransferase , acetylation , chemistry , histone , enzyme , biochemistry , stereochemistry , pharmacology , biology , methylation , amino acid , dna , gene
SETD7 is a histone H3K4 lysine methyltransferase involved in human gene regulation. Aberrant expression of SETD7 has been associated with various diseases, including cancer. Therefore, SETD7 is considered a good target for the development of new epigenetic drugs. To date, few selective small‐molecule inhibitors have been reported that target SETD7, the most potent being ( R )‐PFI‐2. Herein we report structure–activity relationship studies on ( R )‐PFI‐2 and its analogues. A library of 29 structural analogues of ( R )‐PFI‐2 was synthesized and evaluated for inhibition of recombinantly expressed human SETD7. The key interactions were found to be a salt bridge and a hydrogen bond formed between ( R )‐PFI‐2′s NH 2 + group and SETD7′s Asp256 and His252 residue, respectively.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom